FGFR2 and intrahepatic cholangiocarcinoma: For instance, a substantial percentage of intrahepatic cholangiocarcinomas have been shown to bear mutations in the isocitrate dehydrogenase 1 and 2 genes or express oncogenic fusion proteins between the fibroblast growth factor receptor 2 (FGFR2) gene and several partner proteins [42,43].